Intellia Therapeutics, Inc. (LON:0JBU)

Intellia Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	630	949	2,144	2,468	6,498	2,574
Market Cap Growth	-72.79%	-55.75%	-13.15%	-62.02%	152.49%	375.34%
Enterprise Value	187	275	1,457	1,845	5,706	2,291
Last Close Price	5.98	9.29	24.19	28.48	88.62	44.11
PS Ratio	17.86	20.52	75.27	57.06	266.22	60.59
PB Ratio	1.04	1.36	2.60	2.41	8.46	6.67
P/TBV Ratio	1.04	1.36	2.60	2.41	8.46	6.67
EV/Sales Ratio	5.46	5.95	51.17	42.65	233.76	53.94
EV/FCF Ratio	-0.63	-	-	-	-	-
Debt / Equity Ratio	0.15	0.24	0.11	0.11	0.07	0.08
Asset Turnover	0.04	0.05	0.03	0.04	0.03	0.12
Quick Ratio	4.57	5.50	8.23	9.45	5.97	9.33
Current Ratio	4.90	5.77	8.66	9.62	6.11	9.60
Return on Equity (ROE)	-57.92%	-54.01%	-42.10%	-41.67%	-34.19%	-33.69%
Return on Assets (ROA)	-30.12%	-26.80%	-22.83%	-20.35%	-16.99%	-16.89%
Return on Capital (ROIC)	-33.05%	-29.71%	-25.44%	-23.09%	-19.92%	-19.98%
Earnings Yield	-64.63%	-43.70%	-17.62%	-15.95%	-3.04%	-3.82%
FCF Yield	-46.84%	-29.87%	-14.95%	-11.66%	-2.70%	-1.52%
Buyback Yield / Dilution	-11.19%	-11.35%	-15.33%	-8.57%	-26.63%	-18.50%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.